Skip to main content
logo
XBiotech Inc. (XBIT)
NASDAQ: XBIT · Real-Time Price · USD
2.250
-0.020 (-0.88%)
Jul 29, 2026, 4:00 PM EDT - Market closed

XBiotech Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
----4.0118.39
Revenue Growth
-----78.20%-58.19%
Gross Profit
----3.3612.57
Operating Income
-48.41-55.69-42.47-37.51-34.49-25.08
Net Income
-40.16-45.54-38.53-24.56-32.9-17.41
Earnings Per Share
-1.32-1.49-1.26-0.81-0.32-0.58
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
115.46125.55172.68200.02217.48236.98
Total Debt
0010.25000
Net Cash (Debt)
115.46125.55162.43200.02217.48236.98
Net Cash Growth
-25.94%-22.70%-18.80%-8.03%-8.23%-0.16%
Net Cash Per Share
3.794.125.336.575.727.89

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-42.17-39.92-30.96-18.73-14.8269.45
Capital Expenditures
-0.2-0.29-1.3-0.36-0.59-3.53
Free Cash Flow
-42.36-40.21-32.27-19.09-15.4165.92
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
----83.77%68.36%
Operating Margin
-----860.10%-136.36%
Pretax Margin
-----837.61%-138.40%
Profit Margin
-----854.76%-182.13%
FCF Margin
-----384.26%358.38%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-87.6387.6387.6387.6387.63
P/FCF Ratio
-----5.14
PS Ratio
----26.6418.42